Objectives The aim of this study was to confirm the synergistic effect of colistin/rifampicin
combination therapy compared with colistin monotherapy in pneumonia caused by colistin …

Objectives To investigate clinical and microbiological response, and 30-day mortality of
pneumonia involving multidrug-resistant (MDR) Acinetobacter calcoaceticus-Acinetobacter …

The ratio of the area under the free (unbound) concentration–time curve to minimum
inhibitory concentration (fAUC/MIC) was proposed to be the pharmacokinetic …

Purpose: To evaluate the outcomes of the patients who were infected with colistin-only-
susceptible (COS) Acinetobacter baumannii and treated with either colistin monotherapy or …

Purpose Extensively drug-resistant Acinetobacter baumannii (XDRAB) is an important cause
of nosocomial pneumonia with limited therapeutic options. Colistin-based regimen is the …

Multidrug resistant among Acinetobacter baumannii infection is associated with a high
mortality rate and limits the therapeutic options. The aim of this study was to assess the …

BACKGROUND Nosocomial infections with carbapenem-resistant Acinetobacter baumannii-
calcoaceticus complex (ABC) strains are great problem for intensive care units. ABC strains …

Data for treatment and outcomes of extensively drug-resistant Acinetobacter baumannii
(XDR-AB) pneumonia are limited. A retrospective cohort study of 236 adult patients with …

Emerging resistance to colistin in Acinetobacter baumannii clinical strains is concerning
because of the limited therapeutic choices for these important clinical pathogens. We …

Background. Extensively drug-resistant (XDR) Acinetobacter baumannii may cause serious
infections in critically ill patients. Colistin often remains the only therapeutic option. Addition …